title: Study of response to naproxen in patients with hepatocellular carcinoma who developed fever following transcatheter arterial embolization.
abstract: Good antipyretic response was obtained when naproxen was given at 600 mg/day for about one week to patients who developed fever after transcatheter arterial embolization (TAE). Fever recurred in several patients, but subsided again when naproxen was given at 300 mg/day. No patients developed gastric mucosal lesions of clinical concern that seemed to be related to naproxen.
authors.affiliation: Department of Internal Medicine, Nishiyodo Hospital, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Akaji
authors.forename: M
authors.initials: M
authors.lastname: Hagino
authors.forename: K
authors.initials: K
authors.lastname: Inoue
authors.forename: N
authors.initials: N
authors.lastname: Hirota
authors.forename: H
authors.initials: H
authors.lastname: Nakamura
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D009288:Naproxen / Q000627:therapeutic use*
chemical_list: D009288:Naproxen